Zdrowie i gospodarka · 15/12/1995
Datascope Corp.; Premarket Approval of the VasoSeal Vascular Hemostasis Device
The Food and Drug Administration (FDA) is announcing its approval of the application by Datascope Corp., Montvale, NJ, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the VasoSeal Vascular Hemostasis Device (VHD). FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 29, 1995, of the approval of the application.